Fox, Kevin R.
10955  Ergebnisse:
Personensuche X
?
3

Does time to adjuvant chemotherapy (TTC) affect outcomes in..:

Pomponio, Maria K. ; Keele, Luke J. ; Fox, Kevin R....
Breast Cancer Research and Treatment.  177 (2019)  1 - p. 137-143 , 2019
 
?
6

Micrometastases in Axillary Sentinel Lymph Nodes: How Signi..:

Fox, Kevin R.
Current Oncology Reports.  12 (2010)  1 - p. 4-6 , 2010
 
?
7

Duration of Chemotherapy for Early Stage Breast Cancer: Hav..:

Hirsh, Rebecca L. ; Fox, Kevin R.
Current Treatment Options in Oncology.  11 (2010)  3-4 - p. 59-62 , 2010
 
?
8

Adding Zoledronic Acid to Endocrine Therapy in the Adjuvant..:

Fox, Kevin R.
Current Oncology Reports.  12 (2010)  1 - p. 1-3 , 2010
 
?
9

HER2 Blockade: Is Combination Therapy Better Than Monothera..:

Hirsh, Rebecca L. ; Fox, Kevin R.
Current Treatment Options in Oncology.  11 (2010)  3-4 - p. 63-65 , 2010
 
?
10

Adding bevacizumab to paclitaxel in the first-line treatmen..:

Fox, Kevin R.
Current Oncology Reports.  11 (2008)  1 - p. 5-7 , 2008
 
?
11

Clinical trials report:

Fox, Kevin R.
Current Oncology Reports.  10 (2008)  1 - p. 7-9 , 2008
 
?
12

Estimating the costs of chemotherapy-associated adverse eve..:

Weiner, Mark G. ; Ross, Sara J. ; Mathew, Justin I....
Health Services and Outcomes Research Methodology.  7 (2007)  1-2 - p. 1-21 , 2007
 
?
 
1-15